問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Cathay General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-04-13 - 2027-05-05
Condition/Disease
Test Drug
Participate Sites12Sites
Recruiting12Sites
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2025-06-01 - 2026-12-31
Participate Sites9Sites
Recruiting9Sites
2026-01-01 - 2032-03-10
Participate Sites15Sites
Not yet recruiting8Sites
Recruiting7Sites
2025-09-30 - 2032-03-31
Participate Sites11Sites
Recruiting11Sites
2023-06-01 - 2027-12-31
Participate Sites19Sites
Not yet recruiting1Sites
Recruiting18Sites
2024-08-26 - 2026-07-23
Participate Sites7Sites
2025-04-01 - 2026-03-31
Participate Sites1Sites
Recruiting1Sites
2021-12-04 - 2023-12-31
-
Participate Sites10Sites
Recruiting10Sites
2024-07-01 - 2027-12-31
chronic kidney disease
placebo ‧ BI 690517 Empagliflozin
Participate Sites23Sites
Recruiting23Sites
全部
